News Reader
03-30-2009, 08:36 PM
The U.S. Food and Drug Administration today approved Afinitor oral tablets (everolimus) for the treatment of patients with advanced kidney cancer whose disease has progressed after treatment with other cancer therapies.
More... (http://www.fda.gov/bbs/topics/NEWS/2009/NEW01980.html)
More... (http://www.fda.gov/bbs/topics/NEWS/2009/NEW01980.html)